Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Cancers|February 7, 2018
Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like FeaturesNidhi Gupta, Keshav Gopal, Chengsheng Wu, et al.
Oncotarget|December 20, 2015
Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporterKeshav Gopal, Nidhi Gupta, Haifeng Zhang, et al.
Diabetologia|June 3, 2018
Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat dietRami Al Batran, Keshav Gopal, Mackenzie D Martin, et al.
Breast Cancer Research : BCR|November 9, 2014
Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarraysKaren Jung, Peng Wang, Nidhi Gupta, et al.
Basic & Clinical Pharmacology & Toxicology|June 3, 2023
The antianginal ranolazine fails to improve glycaemia in obese liver-specific pyruvate dehydrogenase deficient male miceChristina T Saed, Seyed Amirhossein Tabatabaei Dakhili, Amanda A Greenwell, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 29, 2023
Defective muscle ketone body oxidation disrupts BCAA catabolism by altering mitochondrial branched-chain aminotransferaseHamza Mechchate, Abdualrahman Mohammed Abdualkader, James Bradshaw Bernacchi, et al.
Blood|April 30, 2015
STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphomaChengsheng Wu, Ommoleila Molavi, Haifeng Zhang, et al.
Oncotarget|April 15, 2015
Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporterKaren Jung, Nidhi Gupta, Peng Wang, et al.
The Canadian Journal of Cardiology|July 9, 2020
The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic CardiomyopathyMalak Almutairi, Keshav Gopal, Amanda A Greenwell, et al.
Cell Reports|April 7, 2021
FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activityKeshav Gopal, Rami Al Batran, Tariq R Altamimi, et al.
Pageof 6